1 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
2 |
Alx-0081 |
- |
- |
- |
- |
064 1件: 64 💬 |
3 |
Anfibatide |
Anfibatide |
- |
- |
- |
064 1件: 64 💬 |
4 |
Anti-von willebrand factor nanobody |
Von Willebrand Factor Human |
- |
- |
- |
064 1件: 64 💬 |
5 |
Anti-von willebrand factor nanobody, caplacizumab |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
6 |
Anti-von willebrand factor nanobody, inn = caplacizumab |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
7 |
Apadamtase alfa |
Apadamtase alfa |
- |
- |
- |
064 1件: 64 💬 |
8 |
Apademtase alfa |
- |
- |
- |
- |
064 1件: 64 💬 |
9 |
Arc 1779 |
- |
- |
- |
- |
064 2件: 64, 288 💬 |
10 |
Arc1779 |
- |
- |
- |
- |
064 2件: 64, 288 💬 |
11 |
Arc1779 injection |
- |
- |
- |
- |
064 2件: 64, 288 💬 |
12 |
Bax930 |
- |
- |
- |
- |
064 1件: 64 💬 |
13 |
Bax930 - recombinant human adamts13 |
- |
- |
- |
- |
064 1件: 64 💬 |
14 |
Bax930 or shp655 |
- |
- |
- |
- |
064 1件: 64 💬 |
15 |
Cablivi |
- |
- |
- |
- |
064 1件: 64 💬 |
16 |
Caplacizumab |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
17 |
Caplacizumab (alx-0081) |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
18 |
Caplacizumab (an anti-von willebrand factor nanobody alx-0081) |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
19 |
Caplacizumab (an anti-von willebrand factor nanobody) |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
20 |
Corticosteroid treatment (methylprednisolone or prednisolone) |
Methylprednisolone |
14件: D00407 D00407, D00472 D00472, D00751 D00751, D00979 D00979, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
064 1件: 64 💬 |
21 |
Corticosteroids |
- |
- |
- |
- |
041 10件: 41, 46, 49, 64, 97, 107, 164, 220, 296, 300 💬 |
22 |
Cryosupernatant plasma |
- |
- |
- |
- |
064 1件: 64 💬 |
23 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
24 |
Danazol |
Danazol |
1件: D00289 D00289 💬 |
AR 3件: AR, ESR1, PGR 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
060 5件: 60, 63, 64, 65, 285 💬 |
25 |
Desmopressin |
Desmopressin |
2件: D00291 D00291, D02235 D02235 💬 |
AVPR2 2件: AVPR2, F8 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
006 5件: 6 , 64, 72, 225, 288 💬 |
26 |
Desmopressin acetate |
Acetate |
2件: D00291 D00291, D02235 D02235 💬 |
AVPR2 2件: AVPR2, F8 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
064 2件: 64, 288 💬 |
27 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
28 |
Hmed-ides |
Imlifidase |
1件: D11470 D11470 💬 |
- |
- |
064 2件: 64, 221 💬 |
29 |
Idec-c2b8, ro 45-2294 |
- |
- |
- |
- |
064 1件: 64 💬 |
30 |
Ides |
Imlifidase |
1件: D11470 D11470 💬 |
- |
- |
064 2件: 64, 221 💬 |
31 |
Ides (0.25 mg/kg) |
Imlifidase |
1件: D11470 D11470 💬 |
- |
- |
064 1件: 64 💬 |
32 |
Ides (0.50 mg/kg) |
Imlifidase |
1件: D11470 D11470 💬 |
- |
- |
064 1件: 64 💬 |
33 |
Immunosuppressive treatment (eg, rituximab) |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
064 1件: 64 💬 |
34 |
Mabthera |
- |
- |
- |
- |
011 22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
35 |
Magnesium |
Magnesium |
- |
- |
- |
006 16件: 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
36 |
Masp-2 antibody |
Narsoplimab |
1件: D11531 D11531 💬 |
MASP2 1件: MASP2 💬 |
Complement and coagulation cascades 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
064 2件: 64, 109 💬 |
37 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
38 |
Minirin |
- |
- |
- |
- |
064 2件: 64, 288 💬 |
39 |
Octaplas |
- |
- |
- |
- |
064 1件: 64 💬 |
40 |
Octaplas infusion |
- |
- |
- |
- |
064 1件: 64 💬 |
41 |
Octaplas sd |
- |
- |
- |
- |
064 1件: 64 💬 |
42 |
Octaplaslg® |
- |
- |
- |
- |
064 1件: 64 💬 |
43 |
Octaplas®lg |
- |
- |
- |
- |
064 1件: 64 💬 |
44 |
Octostim |
- |
- |
- |
- |
064 2件: 64, 288 💬 |
45 |
Oms721 |
- |
- |
- |
- |
064 3件: 64, 66, 109 💬 |
46 |
Oms721 100 mg/ml injection solution, oms00620646, oms620646, masp-2 antibody |
Narsoplimab |
1件: D11531 D11531 💬 |
MASP2 1件: MASP2 💬 |
Complement and coagulation cascades 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
064 2件: 64, 109 💬 |
47 |
Oms721 185 mg/ml injection solution, oms00620646, oms620646, masp-2 antibody |
Narsoplimab |
1件: D11531 D11531 💬 |
MASP2 1件: MASP2 💬 |
Complement and coagulation cascades 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
064 2件: 64, 109 💬 |
48 |
Other: standard of care |
- |
- |
- |
- |
013 7件: 13, 49, 64, 85, 96, 245, 246 💬 |
49 |
Plasma exchange (pe) |
- |
- |
- |
- |
064 1件: 64 💬 |
50 |
Pooled plasma (human), solvent/detergent treated |
- |
- |
- |
- |
064 1件: 64 💬 |
51 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
52 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
53 |
Procedure: plasma exchange |
- |
- |
- |
- |
013 5件: 13, 43, 44, 64, 222 💬 |
54 |
Radamts-13 |
- |
- |
- |
- |
064 1件: 64 💬 |
55 |
Recombinant a disintegrin and metalloproteinase thrombospondin type-1 motifs 13 |
- |
- |
- |
- |
064 1件: 64 💬 |
56 |
Recombinant a disintegrin and metalloproteinase with thrombospondin type-1 |
- |
- |
- |
- |
064 1件: 64 💬 |
57 |
Recombinant a disintegrin and metalloproteinase with thrombospondin type-1 motifs |
- |
- |
- |
- |
064 1件: 64 💬 |
58 |
Recombinant a disintegrin and metalloproteinase with thrombospondin type-1 motifs 13 |
- |
- |
- |
- |
064 1件: 64 💬 |
59 |
Recombinant a disintegrin and metalloproteinase with thrombospondin type-1 motifs 13 (radamts13) |
- |
- |
- |
- |
064 1件: 64 💬 |
60 |
Recombinant adamts13 |
- |
- |
- |
- |
064 1件: 64 💬 |
61 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
62 |
Romiplostim |
Romiplostim |
1件: D08990 D08990 💬 |
MPL 1件: MPL 💬 |
Cytokine-cytokine receptor interaction 2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway |
060 4件: 60, 63, 64, 65 💬 |
63 |
Shp 655 (bax 930) |
- |
- |
- |
- |
064 1件: 64 💬 |
64 |
Shp655 |
- |
- |
- |
- |
064 1件: 64 💬 |
65 |
Standard of care |
- |
- |
- |
- |
006 12件: 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
66 |
Standard plasma |
- |
- |
- |
- |
064 1件: 64 💬 |
67 |
Standrd of care treatment |
- |
- |
- |
- |
064 1件: 64 💬 |
68 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
69 |
Sulfate, magnesium |
Magnesium |
- |
- |
- |
064 1件: 64 💬 |
70 |
Tak-755 orbax930 or shp655 |
- |
- |
- |
- |
064 1件: 64 💬 |
71 |
Uniplas |
- |
- |
- |
- |
064 1件: 64 💬 |
72 |
Von willebrand factor |
Von Willebrand Factor Human |
- |
- |
- |
064 2件: 64, 288 💬 |